ARTICLE | Financial News
Viracta raises $18.4M, strikes NantKwest deal
April 4, 2017 2:38 PM UTC
Viracta Therapeutics Inc. (San Diego, Calif.) closed the first tranche of an $18.4 million series B round led by new investor NantKwest Inc. (NASDAQ:NK).
New investor Wicklow Capital and existing investors Latterell Venture Partners and Forward Ventures also participated. Details regarding the round's tranches are undisclosed...